Maynard Um
-
-
-
-
-
-
-
Acadia Pharma (ACAD) call put ratio 6.8 calls to 1 put with a focus on July 25 calls
-
-
-
-
-
-
-
ACADIA Pharmaceuticals launches powder formulation of Rett syndrome drug
-
-
-
-
-
-
-
Acadia Pharmaceuticals (ACAD) PT Raised to $20 at Jefferies
-
-
-
-
-
-
-
Acadia Pharmaceuticals (ACAD) PT Raised to $23 at Oppenheimer
-
-
-
-
-
-
-
Acadia Pharma anticipates 2025 net sales to exceed $1 billion
-
-
-
-
-
-
-
Where can biotech stocks go from here? RBC answers
-
-
-
-
-
-
-
Mizuho Reiterates Neutral Rating on Acadia Pharmaceuticals (ACAD)
-
420,187 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

